Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

G.R. Burmester, P. Mease, B.A.C. Dijkmans, K. D. Gordon, D. Lovell, R. Panaccione, J.G. Perez, A.L. Pangan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1863-1869
JournalAnnals of the Rheumatic Diseases
Volume68
Issue number12
DOIs
Publication statusPublished - 2009

Cite this